Vaccine Therapy With or Without Imiquimod in Treating Patients Who Have Undergone Surgery for Stage II, Stage III, or Stage IV Melanoma
Clinical trial NCT00118313 · COMPLETED
Trial details
- NCT number
- NCT00118313
- Sponsor
- Craig L Slingluff, Jr
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2004-11-04
- Primary completion
- 2006-07-28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.